Lee, Danner & Bass’s Bristol-Myers Squibb BMY Stock Holding History

Lee, Danner & Bass’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	31,718 -123	-0.4%	-$7.06K	0.11%	127
2026 Q1	$1.93M	Sell	31,841 -1,087	-3%	-$63.4K	0.12%	120
2025 Q4	$1.78M	Sell	32,928 -366	-1%	-$17.6K	0.13%	114
2025 Q3	$1.5M	Buy	33,294 +1,561	+5%	+$72.9K	0.11%	121
2025 Q2	$1.47M	Hold	31,733	–	–	0.11%	118
2025 Q1	$1.94M	Sell	31,733 -110	-0.3%	-$6.41K	0.16%	103
2024 Q4	$1.8M	Sell	31,843 -258	-0.8%	-$14.4K	0.14%	110
2024 Q3	$1.66M	Buy	32,101 +569	+2%	+$26.7K	0.12%	109
2024 Q2	$1.31M	Buy	+31,532	New	+$1.41M	0.1%	123
2023 Q4	$2.35M	Sell	45,853 -24,621	-35%	-$1.29M	0.2%	95
2023 Q3	$4.09M	Sell	70,474 -2,256	-3%	-$138K	0.37%	59
2023 Q2	$4.65M	Sell	72,730 -2,320	-3%	-$156K	0.4%	56
2023 Q1	$5.2M	Sell	75,050 -190	-0.3%	-$13.4K	0.48%	49
2022 Q4	$5.41M	Sell	75,240 -226	-0.3%	-$17K	0.51%	46
2022 Q3	$5.37M	Sell	75,466 -517	-0.7%	-$37.5K	0.57%	42
2022 Q2	$5.85M	Sell	75,983 -1,135	-1%	-$86.4K	0.59%	44
2022 Q1	$5.63M	Sell	77,118 -1,765	-2%	-$119K	0.48%	53
2021 Q4	$4.92M	Sell	78,883 -8,075	-9%	-$474K	0.42%	59
2021 Q3	$5.14M	Buy	86,958 +4,213	+5%	+$277K	0.47%	55
2021 Q2	$5.53M	Sell	82,745 -1,472	-2%	-$96K	0.5%	51
2021 Q1	$5.32M	Buy	84,217 +378	+0.5%	+$23.5K	0.51%	51
2020 Q4	$5.2M	Sell	83,839 -1,359	-2%	-$83.6K	0.55%	48
2020 Q3	$5.14M	Sell	85,198 -5,120	-6%	-$308K	0.61%	45
2020 Q2	$5.31M	Buy	90,318 +24,849	+38%	+$1.49M	0.68%	45
2020 Q1	$3.65M	Buy	65,469 +3,595	+6%	+$220K	0.52%	50
2019 Q4	$3.97M	Buy	61,874 +17,136	+38%	+$981K	0.42%	65
2019 Q3	$2.27M	Buy	44,738 +100	+0.2%	+$4.7K	0.24%	85
2019 Q2	$2.02M	Hold	44,638	–	–	0.21%	89
2019 Q1	$2.13M	Sell	44,638 -175	-0.4%	-$8.72K	0.23%	82
2018 Q4	$2.33M	Sell	44,813 -403	-0.9%	-$21.7K	0.27%	78
2018 Q3	$2.81M	Sell	45,216 -125	-0.3%	-$7.42K	0.28%	76
2018 Q2	$2.51M	Hold	45,341	–	–	0.27%	79
2018 Q1	$2.87M	Buy	45,341 +3	+0%	+$193	0.3%	76
2017 Q4	$2.78M	Sell	45,338 -1,966	-4%	-$123K	0.28%	80
2017 Q3	$3.02M	Buy	47,304 +1,185	+3%	+$69.2K	0.32%	70
2017 Q2	$2.57M	Sell	46,119 -246	-0.5%	-$13.4K	0.29%	77
2017 Q1	$2.52M	Sell	46,365 -973	-2%	-$53.4K	0.28%	75
2016 Q4	$2.77M	Buy	47,338 +2,720	+6%	+$149K	0.33%	68
2016 Q3	$2.41M	Buy	44,618 +600	+1%	+$38.5K	0.29%	70
2016 Q2	$3.24M	Buy	44,018 +424	+1%	+$30K	0.39%	61
2016 Q1	$3.09M	Hold	43,594	–	–	0.38%	61
2015 Q4	$3M	Hold	43,594	–	–	0.39%	62
2015 Q3	$2.58M	Buy	43,594 +9	+0%	+$571	0.34%	64
2015 Q2	$2.9M	Hold	43,585	–	–	0.35%	66
2015 Q1	$2.81M	Sell	43,585 -100	-0.2%	-$6.26K	0.33%	64
2014 Q4	$2.58M	Buy	43,685 +7	+0%	+$395	0.31%	64
2014 Q3	$2.23M	Buy	43,678 +2,583	+6%	+$129K	0.28%	71
2014 Q2	$1.99M	Buy	41,095 +2,859	+7%	+$141K	0.24%	73
2014 Q1	$1.99M	Hold	38,236	–	–	0.26%	69
2013 Q4	$2.03M	Buy	38,236 +942	+3%	+$48K	0.27%	65
2013 Q3	$1.73M	Hold	37,294	–	–	0.24%	70
2013 Q2	$1.67M	Buy	+37,294	New	+$1.62M	0.24%	67

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Lee, Danner & Bass's BMY Position: Q2 2026 in Review

Lee, Danner & Bass reduced its Bristol-Myers Squibb (BMY) stake by 0.39% in Q2 2026, selling an estimated $7.06K and leaving 31,718 shares worth $1.83M. The position accounts for 0.11% of the portfolio, ranked #127.

Lee, Danner & Bass first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.85M in Q2 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Lee, Danner & Bass held 31,718 shares of Bristol-Myers Squibb worth $1.83M as of Q2 2026.
Lee, Danner & Bass sold 123 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.06K.
Bristol-Myers Squibb made up 0.11% of Lee, Danner & Bass's portfolio in Q2 2026, its #127 holding.
Lee, Danner & Bass first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Lee, Danner & Bass's Bristol-Myers Squibb position peaked at $5.85M in Q2 2022.
879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.